Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is YiChang HEC ChangJiang Pharmaceutical Co., Ltd. ?
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Operating profit has grown by an annual rate -24.10% of over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
Poor long term growth as Operating profit has grown by an annual rate -24.10% of over the last 5 years
3
The company declared negative results in Dec'24 after flat results in Jun'24
- INTEREST COVERAGE RATIO(Q) Lowest at 83.99
- RAW MATERIAL COST(Y) Grown by 13.61% (YoY)
- INVENTORY TURNOVER RATIO(HY) Lowest at 1.77%
4
With ROE of 6.75%, it has a Expensive valuation with a 1.33 Price to Book Value
- Over the past year, while the stock has generated a return of 73.17%, its profits have fallen by -76.6%
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is YiChang HEC ChangJiang Pharmaceutical Co., Ltd. for you?
Medium Risk, High Return
Absolute
Risk Adjusted
Volatility
YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
73.17%
1.56
44.23%
Hang Seng Hong Kong
27.36%
1.60
30.02%
Quality key factors
Factor
Value
Sales Growth (5y)
-10.58%
EBIT Growth (5y)
-24.10%
EBIT to Interest (avg)
4.55
Debt to EBITDA (avg)
1.00
Net Debt to Equity (avg)
0.05
Sales to Capital Employed (avg)
0.37
Tax Ratio
16.38%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
13.34%
ROE (avg)
10.75%
Valuation Key Factors 
Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
1.33
EV to EBIT
18.02
EV to EBITDA
11.15
EV to Capital Employed
1.31
EV to Sales
3.11
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
7.29%
ROE (Latest)
6.75%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bearish
Bullish
Technical Movement
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is not working for YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
Net Sales
At HKD 1,376.65 MM has Fallen at -58.7%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (HKD MM)
Interest Coverage Ratio
Lowest at 83.99
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Pre-Tax Profit
At HKD -163 MM has Fallen at -111.73%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (HKD MM)
Net Profit
At HKD -125.5 MM has Fallen at -108.49%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (HKD MM)
Net Sales
Lowest at HKD 1,376.65 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (HKD MM)
Operating Profit
Lowest at HKD 39.79 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (HKD MM)
Operating Profit Margin
Lowest at 2.89 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Pre-Tax Profit
Lowest at HKD -163 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (HKD MM)
Net Profit
Lowest at HKD -125.5 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (HKD MM)
EPS
Lowest at HKD -0.25
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (HKD)
Inventory Turnover Ratio
Lowest at 1.77%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Debtors Turnover Ratio
Lowest at 1.71%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 13.61% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






